Get the Stockscreener App
77.29
2.98%
2.24
After Hours:
77.10
-0.19
-0.25%
Corcept Therapeutics Inc stock is traded at $77.29, with a volume of 542.86K.
It is up +2.98% in the last 24 hours and up +2.52% over the past month.
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
See More
Previous Close:
$75.05
Open:
$75.1
24h Volume:
542.86K
Relative Volume:
0.67
Market Cap:
$8.13B
Revenue:
$628.56M
Net Income/Loss:
$141.82M
P/E Ratio:
61.34
EPS:
1.26
Net Cash Flow:
$142.60M
1W Performance:
+2.32%
1M Performance:
+2.52%
6M Performance:
+1.97%
1Y Performance:
+38.22%
1-Day Range:
$74.93
$78.98
1-Week Range:
$73.79
$78.99
52-Week Range:
$49.00
$117.33
Corcept Therapeutics Inc Stock (CORT) Company Profile
Name
Corcept Therapeutics Inc
Sector
Industry
Phone
650.688.8803
Address
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Compare CORT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CORT
Corcept Therapeutics Inc
|
77.29 | 7.89B | 628.56M | 141.82M | 142.60M | 1.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-18-25 | Initiated | Wolfe Research | Peer Perform |
| Nov-06-23 | Upgrade | Truist | Hold → Buy |
| Apr-11-23 | Initiated | SVB Securities | Market Perform |
| Apr-04-23 | Initiated | Piper Sandler | Overweight |
| Feb-15-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-01-22 | Downgrade | Truist | Buy → Hold |
| Jul-27-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-27-22 | Resumed | Canaccord Genuity | Buy |
| Feb-02-22 | Initiated | Canaccord Genuity | Buy |
| Jan-28-22 | Initiated | Truist | Buy |
| Aug-05-20 | Downgrade | Jefferies | Buy → Hold |
| Sep-24-19 | Initiated | Jefferies | Buy |
| Sep-06-19 | Initiated | H.C. Wainwright | Buy |
| Feb-04-19 | Downgrade | B. Riley FBR | Buy → Neutral |
| Aug-10-18 | Reiterated | Stifel | Hold |
| May-31-18 | Downgrade | Stifel | Buy → Hold |
| Mar-09-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Aug-31-17 | Initiated | Stifel | Buy |
| Feb-02-17 | Initiated | Ladenburg Thalmann | Buy |
| Apr-21-15 | Initiated | FBR Capital | Outperform |
| Jan-13-14 | Downgrade | Stifel | Buy → Hold |
| Aug-09-13 | Downgrade | Janney | Buy → Neutral |
| Aug-09-13 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Feb-21-12 | Reiterated | JMP Securities | Mkt Outperform |
| Jan-06-10 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Jul-17-08 | Initiated | Rodman & Renshaw | Mkt Outperform |
| Jun-21-07 | Upgrade | Punk, Ziegel & Co | Mkt Perform → Accumulate |
View All
Corcept Therapeutics Inc Stock (CORT) Latest News
Will Corcept Therapeutics Incorporated stock continue upward momentum - newser.com
Will Corcept Therapeutics Incorporated stock remain a Wall Street favorite - newser.com
Why Corcept Therapeutics Incorporated stock is a value investor pickPortfolio Update Report & Expert Curated Trade Ideas - newser.com
Will Corcept Therapeutics Incorporated stock recover after recent drop2025 Fundamental Recap & AI Powered Trade Plan Recommendations - newser.com
Is Corcept Therapeutics Incorporated (HTD) stock inflation resilient2025 Market Outlook & Fast Exit and Entry Strategy Plans - newser.com
Does Corcept Therapeutics Incorporated (HTD) stock trade below intrinsic valueJuly 2025 PostEarnings & Real-Time Volume Analysis - newser.com
Why Corcept Therapeutics Incorporated (HTD) stock is a must watch tickerMarket Performance Report & Expert Approved Momentum Trade Ideas - newser.com
Will a bounce in Corcept Therapeutics Incorporated offer an exitWeekly Trend Summary & Safe Entry Trade Signal Reports - newser.com
How Corcept Therapeutics Incorporated stock compares to growth peersJuly 2025 Momentum & Safe Capital Growth Trade Ideas - newser.com
How high can Corcept Therapeutics Incorporated stock goWeekly Trend Report & Weekly Setup with ROI Potential - newser.com
Is Corcept Therapeutics Incorporated (HTD) stock undervalued at current priceQuarterly Portfolio Report & Safe Investment Capital Preservation Plans - newser.com
Does Corcept Therapeutics Incorporated qualify in momentum factor screeningJuly 2025 Breakouts & Smart Money Movement Tracker - newser.com
What Does Wall Street Think About Corcept Therapeutics (CORT)? - MSN
Key metrics from Corcept Therapeutics Incorporated’s quarterly dataMarket Activity Report & AI Driven Stock Reports - newser.com
Will Corcept Therapeutics Incorporated (HTD) stock return to pre crash levelsPortfolio Update Report & Long-Term Safe Investment Plans - newser.com
Total assets of Corcept Therapeutics Incorporated. – HAM:HTD - TradingView
What indicators show strength in Corcept Therapeutics IncorporatedJuly 2025 Sentiment & Free Risk Controlled Daily Trade Plans - newser.com
Wolfe Research Initiates Coverage of Corcept Therapeutics (CORT) with Peer Perform Recommendation - Nasdaq
Corcept Therapeutics Inc (HTD.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Wolfe Research Initiates Coverage on Corcept Therapeutics (CORT) with "Peer Perform" Rating | CORT Stock News - GuruFocus
Wolfe Research initiates coverage on Corcept Therapeutics stock with Peerperform rating - Investing.com Canada
Using data models to predict Corcept Therapeutics Incorporated stock movement2025 Market Sentiment & Daily Price Action Insights - newser.com
Is Corcept Therapeutics Incorporated stock positioned well for digital economyWeekly Trade Review & High Win Rate Trade Alerts - newser.com
Corcept Therapeutics Inc Stock (CORT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):